Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Meningioma × 1 year × Clear all

Status

Sponsor Class

Study Type

Interventional 63 Observational 18 Expanded_access 1

Sponsor

Cancer Type

Conditions

Neoplasms 13 Carcinoma, Non-Small-Cell Lung 13 Recurrence 10 Multiple Myeloma 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Prostatic Neoplasms 7 Pancreatic Neoplasms 7 Neuroblastoma 6 Melanoma 6 Ovarian Neoplasms 5 Leukemia, Myeloid, Acute 5 Breast Neoplasms 5 Sarcoma 4 Lymphoma, Large B-Cell, Diffuse 4 Head and Neck Neoplasms 4 Glioblastoma 4 Stomach Neoplasms 3 Non-Muscle Invasive Bladder Neoplasms 3 Neuroectodermal Tumors, Primitive 3 Lung Neoplasms 3 Hematologic Neoplasms 3 Colorectal Neoplasms 3 Cholangiocarcinoma 3 Carcinoma, Squamous Cell 3 Uterine Neoplasms 2 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma, Ewing 2 Primary Myelofibrosis 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07497984 2026-03-27

ITM11 Expanded Access Program

ITM Solucin GmbH

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡